Delivery Order SPE2DB22D2214-SPE2DB24FS4FQ
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,019.86, is for the delivery of Gilenya 0.5 mg capsules with an ultimate completion date of April 29, 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,597.07, is for the supply of Gilenya 0.5 mg capsules. The contract has an ultimate completion date of July 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $8,809.80, is for the supply of Gilenya 0.5 mg capsules and has a period of performance through March 25, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31,...
- The Defense Logistics Agency awarded a delivery order valued at $33,570.41 to AmerisourceBergen Drug Corp for the supply of Gilenya 0.5 mg capsules (30-count units) on October 20, 2025, with an ultimate completion date of October 21, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's...
- This is a $14,686.88 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of the prescription drug GILENYA 0.5 MG CAPSULE 30S. This delivery order was not set aside for any specific business type. The delivery order has an ultimate completion date of August 6, 2024. AmerisourceBergen is a large, for-profit pharmaceutical distributor that holds several Indefinite Delivery Contracts...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order, valued at $69,163.45, is for the supply of the prescription medication Gilenya 0.5 mg capsules. The contract is a firm fixed-price delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $21,307.60 on January 21, 2026, by the Defense Logistics Agency (DLA) for the supply of Gilenya 0.5 mg capsules (30-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 22, 2026. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency Troop Support Medical awarded a $12,350.54 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 capsules of the 0.5 mg dosage of Gilenya, to be delivered to their location in Conshohocken, Pennsylvania between August 11-14, 2023. Amerisourcebergen will fulfill the order for the multiple sclerosis drug from their corporate office division. The delivery order was issued against an existing DLA medical supply vehicle and no subcontractors or...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) on May 7, 2025. The $43,935.58 firm fixed-price delivery order is for the provision of the medication Gilenya 0.5 mg capsules, with a performance period extending to May 8, 2025. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which allows the company...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical worth $8,809.80 to supply Gilenya 0.5 mg capsules. The order was awarded on October 25, 2023 and requires delivery by October 26, 2023. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this order, which was issued against an existing DLA contract vehicle to supply...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB24FS4FQDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $8,349.19 contract is for the delivery of 4,564,170,490 units of the medication Gilenya 0.5 mg capsules. The delivery order has an ultimate completion date of April 5, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order was not set aside for any particular business type.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 4/4/24 |